Maryanne Mariyaselvam – Non-injectable arterial connector (NIC)

Maryanne, a Clinical Research Fellow at the Queen Elizabeth Hospital, Kings Lynn and at Cambridge University Hospitals, Cambridge and currently undertaking a Doctorate at the University of Cambridge in Patient Safety in the NHS brings the NIC innovation.

The Non-Injectable Arterial Connector (NIC) improves the safety of all patients requiring an arterial line in operating theatres and intensive care by preventing wrong route drug administration.

Although it does not happen often, if medication is accidentally given to a patient via the wrong route, there is potential risk of damage to a patient’s blood vessel and surrounding tissue and in extreme circumstances surgical amputation. The NIC is a definitive solution to the problem.

Non-injectable arterial connector (NIC) in the NIA

Since joining the NIA, the NIC has been adopted by thirteen trusts up from five. The NIA has help Maryanne to move from a single trust approach to national level with support from Academic Health Science Networks (AHSNs) across the country.

Clinical testimonial

Of more than 250 clinicians that have used the NIC, our survey results have shown 98% of health care staff believed it was important to have a device that prevented wrong route drug administration and prevent arterial line infections. 28% of respondents said they have personally seen adverse events in their routine clinical practice when using standard arterial lines in the past and 93% believe these would have been prevented had the NIC been in use. 96.5% of staff said the NIC allows increased identification of the arterial line and more than 80% said that the NIC was easy to learn and use and is compatible with standard arterial line equipment. 81% wanted to use the connector after the study was completed and they felt that this was due to both ease of use and to promote patient safety.

Innovator testimonial

“Adoption of the NIC across the NHS has started to gain a real momentum now and it’s fantastic to see so many trusts adopting new practice and using innovation to improve patient safety. The NIA programme has been fundamental in our success over the last few months, opening doors and providing national level support for my project.  At a regional level, AHSNs are a valuable partner, ensuring that local organisations have access to the newest ideas.”